Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport

Search

Close

Enter Search Terms

Emily L. Hussey

Emily L. Hussey

ID: 1b836575-2619-30fb-68c4

/

Claimed Record

/

Organization: Reed Smith LLP

FDA Proposed Rule Establishes Criteria for Difficult Drugs to Compound Under Sections 503A and 503B

Health Industry Washington Watch · April 2, 2024

FDA publishes new draft guidance on animal drug compounding

Life Sciences Legal Update · November 25, 2019

FDA Partners with the National Association of Boards of Pharmacy to Create an Information-Sharing System for Drug Compounding Activities

Life Sciences Legal Update · October 7, 2019

Outsourcing Facility Athenex Withdraws Appeal of District Court’s Ruling on FDA’s Placement of Bulk Drug Substances on its “Clinical Need” List

Life Sciences Legal Update · September 27, 2019

FDA Announces Public Hearing on Regulation of Cannabis and Cannabis-Derived Products

Life Sciences Legal Update · April 29, 2019

Previous

12

Next

Practice Areas

Health Care and Life Sciences

Food, Drug & Agriculture

Jurisdictions

Publishing Record

Publisher Since 2017

Total Articles 10

Most Recent April 2, 2024

Cite This Author

Emily L. Hussey, Reed Smith LLP

LexBlog Author ID:

1b836575-2619-30fb-68c4

www.lexblog.com/author/ehussey

Contact

FirmReed Smith LLP

Emailehussey@reedsmith.com

BlogsHealth Industry Washington Watch

Life Sciences Legal Update

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog